COVID-19-Associated Myocarditis: An Evolving Concern in Cardiology and Beyond

Meg Fraser, Arianne Clare C. Agdamag, Valmiki R. Maharaj, Melinda Mutschler, Victoria Charpentier, Mohammed Chowdhury, Tamas Alexy

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


The direct and indirect adverse effects of SARS-CoV-2 infection on the cardiovascular sys-tem, including myocarditis, are of paramount importance. These not only affect the disease course but also determine clinical outcomes and recovery. In this review, the authors aimed at providing an update on the incidence of Coronavirus disease-2019 (COVID-19)-associated myocarditis. Our knowledge and experience relevant to this area continues to evolve rapidly since the beginning of the pandemic. It is crucial for the scientific and medical community to stay abreast of current infor-mation. Contrasting early reports, recent data suggest that the overall incidence of SARS-CoV-2-associated myocarditis is relatively low, yet infected individuals are at a substantially increased risk. Therefore, understanding the pathophysiology and diagnostic evaluation, including the use of serum biomarkers and imaging modalities, remain important. This review aims to summarize the most recent data in these areas as they relate to COVID-19-associated myocarditis. Given its increasing relevance, a brief update is included on the proposed mechanisms of myocarditis in COVID-19 vaccine recipients.

Original languageEnglish (US)
Article number520
Issue number4
StatePublished - Apr 2022

Bibliographical note

Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.


  • COVID-19
  • biomarkers
  • cardiac imaging
  • myocarditis

PubMed: MeSH publication types

  • Journal Article
  • Review


Dive into the research topics of 'COVID-19-Associated Myocarditis: An Evolving Concern in Cardiology and Beyond'. Together they form a unique fingerprint.

Cite this